If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
59.50    0.00 (0.00%)
Bid:
59.00
Ask:
60.00
Spread: 1.00 (1.695%)
Market Cap: £14.50m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Half Year Trading Update

7 Jul 2017 07:00

RNS Number : 3843K
MyCelx Technologies Corporation
07 July 2017
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").This inside information is now considered to be in the public domain.

7 July 2017

MYCELX TECHNOLOGIES CORPORATION

("MYCELX" or the "Company")

Half Year Trading Update

 

Notification of Half Year Results

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide, is today providing a brief trading update ahead of its half year results, which will be announced on 13 September 2017.

MYCELX is pleased to confirm that H1 2017 revenues were in line with the Board's expectations. This follows an active first half of the year which, as previously announced, included the first contract award in the Nigerian Oil and Gas market, as well as a contract with a new SABIC affiliate customer. The Nigerian win represents the first conversion of several opportunities that MYCELX actively nurtured with customers last year with extended onsite trials alongside the operators. The addition of another SABIC affiliate customer builds on the strong footprint that we have developed in Saudi Arabia over the last seven years and reflects our focused business development efforts in the Middle East. The Board is also pleased with the progress of the global product launch of MYCELX RE-GEN currently underway with Schlumberger. The Company remains on track to meet current guidance of being operationally cash neutral for the full year ending 31 December 2017 and we look forward to providing further updates in relation to MYCELX's progress in due course.

 

Commenting on today's announcement, Connie Mixon, CEO, said:

"The Oil and Gas and petrochemical sectors have reset their cost structures and are cautiously investing in technology upgrades that support their future operational and business goals. Our contract wins in H1 illustrate the Company's successful initiatives to reach markets that greatly benefit from MYCELX's cost effective, advanced technology such as opening the market in Nigeria as well as further penetration in Saudi Arabia, a market we have operated in for over seven years. The Company remains committed to tight cost controls and will continue to allocate resources to sales and engineering in support of achieving our revenue goals in 2017 and beyond."

 

For further information please contact: 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

Tel: +1 888 306 6843

Cantor Fitzgerald Europe - NOMAD and Broker

Andrew Craig

Richard Salmond

 

 

Tel: +44 20 7894 7000

Celicourt Communications

Mark Antelme

Joanna Boon

 

Tel: +44 20 7520 9266

 

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKADPABKDDOK
Date   Source Headline
3rd Dec 201511:33 amRNSBlocklisting Interim Review
1st Oct 20157:00 amRNSProgress Update on Trials
10th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSRestricted Common Shares to be Traded in CREST
20th Aug 20157:00 amRNSDirector Resignation
17th Aug 20157:00 amRNSProgress Report on Trials and Cost Reduction
29th Jul 20152:01 pmRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Statement
1st Jul 20157:00 amRNSChange of Adviser
5th Jun 20157:00 amRNSDirector/PDMR Shareholding
28th May 20159:48 amRNSBlocklisting Interim Review
21st May 20153:01 pmRNSDirector/PDMR Shareholding
19th May 20154:01 pmRNSResult of Annual Meeting
19th May 20157:00 amRNSAnnual Meeting Statement
17th Apr 20157:00 amRNSMailing of 2014 Annual Report & Notice of AGM
20th Mar 20157:00 amRNS2014 Preliminary Results
15th Jan 20155:39 pmRNSTrading Update
5th Jan 20157:00 amRNSClose of US Placing
2nd Jan 201512:00 pmRNSHolding(s) in Company
22nd Dec 201412:54 pmRNSHolding(s) in Company
10th Dec 20147:00 amRNSEquity Placing
2nd Dec 20147:00 amRNSEquity Placing
27th Nov 20143:58 pmRNSBlocklisting Interim Review
19th Nov 20147:00 amRNSTrading Statement
12th Sep 20147:00 amRNSHalf Year Results Statement
26th Aug 20147:00 amRNSMiddle East Contract Win
7th Jul 20147:00 amRNSHalf Year Trading Update & Contract Wins
13th May 20143:31 pmRNSResult of Annual Meeting
29th Apr 20144:44 pmRNSBlocklisting Interim Review
22nd Apr 201410:02 amRNSAnnual Report & Accounts Posted
20th Mar 20147:00 amRNS2013 Preliminary Results
30th Jan 20147:00 amRNSYear End Trading Update & Contract Wins
10th Dec 20133:29 pmRNSTotal Voting Rights
4th Dec 20133:24 pmRNSHolding(s) in Company
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results
7th Aug 20139:29 amRNSBalance of respective lines of stock
10th Jun 20135:16 pmRNSChange of Main Office Address
3rd Jun 20133:19 pmRNSTotal Voting Rights
28th May 20135:02 pmRNSHolding(s) in Company
28th May 20132:54 pmRNSDirector/PDMR Shareholding
24th May 20138:52 amRNSHolding(s) in Company
14th May 20132:14 pmRNSResult of Annual Meeting
14th May 20137:00 amRNSOperational Update & Directorate Change
9th May 20137:00 amRNSExercise of Warrant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.